Racial disparities in survival in malignant germ cell tumors of the ovary

Emily Hinchcliff*, J. Alejandro Rauh-Hain, Joel T. Clemmer, Elisabeth Diver, Tracilyn Hall, Jennifer Stall, Whitfield Growdon, Rachel Clark, John Schorge

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Objective To investigate racial disparities with respect to adjuvant treatment and survival in patients presenting with malignant ovarian germ cell tumors (OGCT). Methods The National Cancer Database (NCDB) was used to identify women diagnosed with OGCT. Demographic data were abstracted, including stratification by race and histology. Standard univariate and multivariate analyses using logistic regression were performed to describe predictors of adjuvant treatment. Kaplan-Meier and Cox proportional hazards survival methods were used to evaluate racial differences in survival between African American (AA) and white (W) women. Results The study population included 2196 patients, with 1654 (75.3%) W and 328 (14.9%) AA women. Histologic distribution varied significantly by race (p < 0.0001), but neither age nor stage at presentation showed racial differences (p = 0.086 and p = 0.209, respectively). AA received more chemotherapy than W (W: 54.6%, AA: 65.5%, p = 0.008), but in multivariate analysis there was no statistically significant difference in any adjuvant treatment modality. Despite similar treatment, and independent of histology, survival varied significantly by race with 91% (CI 0.89-0.93) five year survival in W patients compared to 84% five year survival in AA (CI 0.8-0.89) (p = 0.02). These disparities were most pronounced in advanced stage disease, with 5 year survival of 84% (CI 0.79-0.89) in W compared to 61% (CI 0.48-0.78) for AA in stage III (p = 0.0002), and 54% (CI 0.42-0.68) compared to 14% (CI 0.03-0.71) for stage IV (p = 0.05). Conclusions AA with OGCT have significantly worse 5 year survival when compared to W patients despite similar rates and modalities of adjuvant treatment.

Original languageEnglish (US)
Pages (from-to)463-469
Number of pages7
JournalGynecologic oncology
Issue number3
StatePublished - Mar 1 2016


  • Ovarian cancer
  • Ovarian germ cell tumors
  • Racial disparities
  • Rare tumors

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology


Dive into the research topics of 'Racial disparities in survival in malignant germ cell tumors of the ovary'. Together they form a unique fingerprint.

Cite this